PLATINUM INVESTMENT MANAGEMENT LTD - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 166 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$1,266,000
-18.0%
68,600
-15.0%
0.04%0.0%
Q2 2018$1,543,000
-4.3%
80,700
-22.8%
0.04%
-20.0%
Q1 2018$1,612,000
+2.9%
104,5000.0%0.04%
+7.1%
Q4 2017$1,566,000
-4.9%
104,5000.0%0.04%0.0%
Q3 2017$1,647,000
-16.5%
104,5000.0%0.04%
-22.2%
Q2 2017$1,972,000
+10.7%
104,5000.0%0.05%
+10.2%
Q1 2017$1,782,000
-2.9%
104,500
-13.0%
0.05%
-9.3%
Q4 2016$1,836,000
-24.7%
120,100
-21.8%
0.05%
-5.3%
Q3 2016$2,439,000
+7.9%
153,600
-11.2%
0.06%
+1.8%
Q2 2016$2,261,000
+19.5%
173,0000.0%0.06%
+33.3%
Q1 2016$1,892,000
+36.1%
173,000
+44.2%
0.04%
+35.5%
Q4 2015$1,390,000
+11.2%
120,0000.0%0.03%
-8.8%
Q3 2015$1,250,000
-13.6%
120,0000.0%0.03%
+17.2%
Q2 2015$1,447,000
-24.6%
120,0000.0%0.03%
-23.7%
Q1 2015$1,920,000
+4.5%
120,0000.0%0.04%
+8.6%
Q4 2014$1,838,000
+18.3%
120,0000.0%0.04%
+9.4%
Q3 2014$1,554,000
-15.5%
120,0000.0%0.03%0.0%
Q2 2014$1,839,000
+57.2%
120,000
+26.3%
0.03%
+52.4%
Q1 2014$1,170,000
+60.1%
95,000
+50.8%
0.02%
+61.5%
Q4 2013$731,000
-1.9%
63,0000.0%0.01%
-7.1%
Q3 2013$745,000
+83.0%
63,000
+53.7%
0.01%
+75.0%
Q2 2013$407,00041,0000.01%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$157,835,70021.26%
AlphaCentric Advisors LLC 292,500$2,816,7751.60%
Quantedge Capital Pte Ltd 179,900$1,732,4370.94%
Intrinsic Value Partners, LLC 50,355$484,9190.62%
Brown Capital Management 3,719,796$35,821,6350.55%
ARMISTICE CAPITAL, LLC 3,456,000$33,281,2800.51%
SummerHaven Investment Management, LLC 67,765$652,5770.48%
BRAIDWELL LP 1,348,099$12,982,1930.41%
AFFINITY INVESTMENT ADVISORS, LLC 50,733$488,5590.32%
EMC Capital Management 43,315$4170.31%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders